Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | 23,974 | reported | 02 Feb 2024 | tx 520+500,326−369,216 |
| Zymeworks Inc. | 7,700 | reported | 12 Jan 2026 | tx 3+81,200 |
| CYTOKINETICS INC | 4,301 | reported | 27 May 2026 | tx 5+50,903 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | CYTOKINETICS INC | 2,851 | 0.00 USD | |
| 27 May 2026 | GRANT_AWARD | CYTOKINETICS INC | 4,301 | 0.00 USD | deriv |
| 12 Jan 2026 | GRANT_AWARD | Zymeworks Inc. | 7,700 | 0.00 USD | deriv |
| 12 Jan 2026 | GRANT_AWARD | Zymeworks Inc. | 11,500 | 0.00 USD | deriv |
| 11 Aug 2025 | GRANT_AWARD | Zymeworks Inc. | 62,000 | 0.00 USD | deriv |
| 14 May 2025 | GRANT_AWARD | CYTOKINETICS INC | 7,333 | 0.00 USD | |
| 14 May 2025 | GRANT_AWARD | CYTOKINETICS INC | 10,880 | 0.00 USD | deriv |
| 10 Feb 2025 | GRANT_AWARD | CYTOKINETICS INC | 25,538 | 0.00 USD | deriv |
| 02 Feb 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 400 | 378.98 USD | |
| 02 Feb 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 281 | 956.65 USD | |
| 02 Feb 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 400 | 0.00 USD | deriv |
| 31 Jan 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 400 | 378.98 USD | |
| 31 Jan 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 282 | 953.42 USD | |
| 31 Jan 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 400 | 0.00 USD | deriv |
| 23 Jan 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 776 | 948.50 USD | |
| 24 Jan 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 500 | 378.98 USD | |
| 24 Jan 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 352 | 951.26 USD | |
| 23 Jan 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,100 | 378.98 USD | |
| 24 Jan 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 500 | 0.00 USD | deriv |
| 23 Jan 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,100 | 0.00 USD | deriv |
| 17 Jan 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 354 | 932.34 USD | |
| 17 Jan 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 500 | 378.98 USD | |
| 17 Jan 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 500 | 0.00 USD | deriv |
| 12 Jan 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 800 | 378.98 USD | |
| 12 Jan 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 568 | 928.18 USD |